|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||33.67 - 34.07|
|52 Week Range||25.55 - 35.60|
|PE Ratio (TTM)||22.27|
|Dividend & Yield||0.90 (2.75%)|
|1y Target Est||N/A|
Bernstein sees opportunity in a buyout target.
AstraZeneca led the FTSE 100 higher on Friday after Bernstein Research said investors were wrong to write off the chances of another takeover approach. Bristol-Myers Squibb is seen as the most likely target ...
AstraZeneca (AZN) needs Investors to pay close attention to the stock based on moves in the options market lately.